CIK 0001588978 · Large accelerated filer
PROCEPT BioRobotics Corp
Sign in to watch- Ticker
- PRCT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260199180
- Phone
- 6502329832
- Business address
- 150 BAYTECH DRIVE, SAN JOSE, CA, 95134
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $114,707
- in 4 filings
Net −$114,707. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-15 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale 10b5-1 | −11,796 | $42.97 | $507K | 46,933 |
| 2023-12-15 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,796 | 29,697 | ||
| 2023-12-14 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option exercise 10b5-1 | +3,204 | $4.56 | $15K | 50,137 |
| 2023-12-14 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale 10b5-1 | −3,204 | $42.95 | $138K | 46,933 |
| 2023-12-14 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,204 | 41,493 | ||
| 2023-12-13 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +71,465 | $4.52 | $323K | 104,988 |
| 2023-12-13 | Waters Kevin EVP, CFO | Sale 10b5-1 | −71,465 | $40.05 | $2.9M | 33,523 |
| 2023-12-13 | Waters Kevin EVP, CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −71,465 | 121,167 | ||
| 2023-12-08 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +6,888 | $4.52 | $31K | 48,608 |
| 2023-12-08 | Waters Kevin EVP, CFO | Sale 10b5-1 | −6,888 | $40.02 | $276K | 33,523 |
| 2023-12-08 | Waters Kevin EVP, CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,888 | 192,632 | ||
| 2023-12-07 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +3,837 | $4.52 | $17K | 41,720 |
| 2023-12-07 | Waters Kevin EVP, CFO | Sale 10b5-1 | −3,837 | $40.00 | $153K | 40,411 |
| 2023-12-07 | Waters Kevin EVP, CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,837 | 199,520 | ||
| 2023-12-06 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option exercise 10b5-1 | +6,096 | $4.52 | $28K | 53,029 |
| 2023-12-06 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale 10b5-1 | −6,096 | $39.96 | $244K | 46,933 |
| 2023-12-06 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,096 | 65,452 | ||
| 2023-12-06 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +4,360 | $4.52 | $20K | 37,883 |
| 2023-12-06 | Waters Kevin EVP, CFO | Sale 10b5-1 | −4,360 | $40.02 | $174K | 44,248 |
| 2023-12-06 | Waters Kevin EVP, CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,360 | 203,357 |
Page 16 of 25 · 483 trades